After an AML diagnosis, treatment often begins right away—leaving little time to process what’s happening, let alone what your lab results mean. In this discussion, AML survivor Steve Buechler speaks with Dr. Alice Mims from The OSU Comprehensive Cancer Center about the key blood and bone marrow tests that guide treatment, track progress, and inform long-term decisions. From CBCs and blast counts to FLT3 and NPM1 mutations, they break down what you need to know moving forward.

Join Dr. Adam Kittai for practical answers to everyday CLL questions. Learn how to translate complex medical topics into human-centered understanding.

What do your CLL blood test results actually mean? In this educational program, Dr. Adam Kittai and CLL patient advocate Michele Nadeem-Baker explain how common tests—like CBC, IGHV, and MRD—help guide diagnosis, prognosis, and when it’s time to start treatment.

Facing a Follicular Lymphoma diagnosis? Dr. Celeste Bello provides a calm, structured guide to help you feel less alone and more informed.

Clear the confusion around DLBCL. Dr. Tycel Phillips answers the questions patients actually ask, focusing on clarity, balance, and radical empathy.

Diffuse large B-cell lymphoma (DLBCL) is fast-moving, but often curable—especially when caught early. Blood work plays a key role throughout diagnosis, treatment, and remission, though many patients are left unsure of what their lab results really mean. In this discussion, Dr. Robyn Stacy-Humphries, a three-time DLBCL survivor, moderates a conversation with lymphoma expert Dr. Tycel Phillips of City of Hope. Together, they unpack what blood tests can (and can’t) tell you, how biopsies and imaging are used, and what markers like LDH, neutrophils, and immunoglobulins mean during and after chemotherapy, CAR T-cell therapy, and beyond.

Explore how blood tests, biopsies, and scans guide follicular lymphoma care—from diagnosis and observation to active treatment. Dr. Celeste Bello breaks down what lab markers really mean and when changes signal it’s time to act.

Radiologist and three-time DLBCL survivor Dr. Robyn Stacy Humphries (Charlotte Radiology) joins Dr. David Prologo (Winship Cancer Institute of Emory University) to explain the imaging tests used in blood cancer care and when each one matters. They also share patient-friendly guidance on pain-relief procedures, ports and PICC lines, and how radiologists and oncologists coordinate your care.

Nicky Greenhalgh, follicular lymphoma patient advocate, and Dr. Jonathan Friedberg, Director of the Wilmot Cancer Institute, hold a special webinar diving into one of the most complex topics in the follicular lymphoma journey: active surveillance.

Dr. Ross Camidge and Nancee Pronsati have a combined perspective you’ll want to hear - an ALK+ lung cancer expert and a decade-long ALK+ survivor, in the same conversation. They’ll cover what to watch for on your current treatment, how to talk to your care team when something feels off, and why adjusting your dose isn’t giving up — it’s part of the plan.

The science is clear: knowing what is driving your specific cancer before you start treatment can change everything about the care you receive. This program will explain why comprehensive biomarker testing is the foundation of the right treatment plan.

What do your blood test results really mean — and how do they help doctors detect or monitor cancer? In this empowering session, hematopathologist Dr. Kamran Mirza joins cancer advocate Stephanie Chuang to break down the most common diagnostic tests, including the CBC.

What do your blood test results really mean — and how do they help doctors detect or monitor cancer? In this empowering session, hematopathologist Dr. Kamran Mirza joins cancer advocate Stephanie Chuang to break down the most common diagnostic tests, including the CBC.

Spend less time in the transfusion chair. Listen to a leading MDS expert discuss the latest in lower-risk MDS treatment, what’s coming, and what they mean for your care.

Lab tests play a central role in diagnosing and managing multiple myeloma, yet they can feel confusing and overwhelming. In this expert conversation, Dr. Brandon Blue of Moffitt Cancer Center sits down with Bryon Daily, a multiple myeloma patient and community leader from The LLS, to break it all down in real terms.